Biotalys Achieves Critical Manufacturing Milestone for First Commercial Biofungicide EVOCA® NG

Biotalys’ First Commercial Biofungicide EVOCA® NG Approved for Large-Scale Commercial Field Trials in the Netherlands

Nextensa: Major lease signed at the new ‘East Corner’ office building in Cloche d’Or

SIPEF subsidiary Tolan Tiga Indonesia signs binding letter of intent to acquire minority stakes in Indonesian Group companies

Nextensa sells Mercator-High5! building to Centre Hospitalier de Luxembourg

Biotalys Achieves Critical Manufacturing Milestone for First Commercial Biofungicide EVOCA® NG

Biotalys’ First Commercial Biofungicide EVOCA® NG Approved for Large-Scale Commercial Field Trials in the Netherlands

Nextensa: Major lease signed at the new ‘East Corner’ office building in Cloche d’Or

SIPEF subsidiary Tolan Tiga Indonesia signs binding letter of intent to acquire minority stakes in Indonesian Group companies

Nextensa sells Mercator-High5! building to Centre Hospitalier de Luxembourg